As activation of NF-kB has been shown in CLL cells to prevent apoptosis [38]–[40], an inducive effect of miR-15/-16 of this pathway is difficult to reconcile with their tumorsuppressive role at least in the tissue analysed here. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.